Markets:

Overview

News

Currencies

International

Treasuries

Bristol-Myers Squibb (NY:BMY)

46.22 +0.28 (+0.61%)

Streaming Delayed Price Updated: 10:31 AM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

82 83 Next >

BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements

May 12, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5.6% year on year to $11.2 billion. The company’s...

Via StockStory

Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket ↗

May 12, 2025

What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the "most consequential executive order" in U.S. history, aimed at lowering prescription...

Via Benzinga

Topics Government

BRISTOL-MYERS SQUIBB CO (NYSE:BMY) stands out as a stock that provides good value for the fundamentals it showcases. ↗

May 09, 2025

BRISTOL-MYERS SQUIBB CO has a stellar value proposition. NYSE:BMY not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point.

Via Chartmill

Earnings Scheduled For April 24, 2025 ↗

April 24, 2025

Via Benzinga

3 Healthcare Stocks in Hot Water

May 09, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Economy Stocks

A Look Into Bristol-Myers Squibb Inc's Price Over Earnings ↗

May 08, 2025

Via Benzinga

Top gainers and losers in the S&P500 index during Wednesday's after-hours session. ↗

May 07, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.

Via Chartmill

FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight ↗

May 06, 2025

FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing.

Via Benzinga

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗

May 06, 2025

Via Benzinga

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

May 06, 2025

From Bristol Myers Squibb

Via Business Wire

FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months ↗

May 02, 2025

FDA extended the aficamten decision deadline to Dec. 26 after classifying the REMS submission as a major amendment to the NDA review.

Via Benzinga

1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar

May 02, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering ↗

April 30, 2025

Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering

Via Chartmill

This High-Yield Pharma Stock Looks Like an Incredible Bargain ↗

April 30, 2025

Via The Motley Fool

Topics Intellectual Property

Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet

April 29, 2025

Recent upticks in the market may disguise the ongoing risks that remain for investors; these factors point to the importance of a defensive strategy.

Via MarketBeat

Topics Economy Government World Trade

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

Top 3 Health Care Stocks That May Rocket Higher In April ↗

April 28, 2025

Via Benzinga

Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 28, 2025

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

Topics Government World Trade

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off ↗

April 26, 2025

Via The Motley Fool

Topics Economy Intellectual Property World Trade

S&P 500 Rallies 2% On Nvidia, Tesla Gains — But Market Mood Stuck In 'Fear' ↗

April 25, 2025

Via Benzinga

Topics Stocks

Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results ↗

April 24, 2025

Via Benzinga

Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact ↗

April 24, 2025

Bristol Myers reported Q1 revenue of $11.2 billion, raised 2025 guidance, and saw strong Growth Portfolio sales offset Legacy product declines.

Via Benzinga

Bristol Myers Reports Upbeat Q1 Earnings, Raises Full-Year Guidance: Retail’s Optimistic ↗

April 24, 2025

The company now expects full-year diluted EPS in the range of $6.70 to $7.00, up from its previous guidance of $6.55 to $6.85.

Via Stocktwits

Topics World Trade

Bristol Myers Continues A Two-Day Losing Spree Despite Walloping Earnings Estimates ↗

April 24, 2025

The company recently faced two big clinical trial setbacks that have weighed on shares recently.

Via Investor's Business Daily

Topics Government

Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday? ↗

April 24, 2025

U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...

Via Benzinga

Topics Government World Trade

Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations

April 24, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 5.6% year on year to $11.2 billion. The company’s...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

April 24, 2025

From Bristol Myers Squibb

Via Business Wire

US Stock Futures Drop Amid Mixed Signals From White House On US-China Trade: 'Focus On Quality In A Diversified Manner,' Says Expert ↗

April 24, 2025

U.S. stock futures fell on Thursday after a two-day advance. Futures of major benchmark indices were lower in premarket.

Via Benzinga

PepsiCo, Alphabet And 3 Stocks To Watch Heading Into Thursday ↗

April 24, 2025

Via Benzinga

Dow Jumps Over 400 Points Amid China Tariff Hopes, Investor Fear Eases: Greed Index Remains In 'Fear' Zone ↗

April 24, 2025

Via Benzinga

Topics Stocks

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

82 83 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Bristol-Myers Squibb (NY:BMY)

All News about Bristol-Myers Squibb

Starting at $3.75/week.

Subscribe Today